Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario

Background : Hyperhomocysteinemia has been proposed as an important risk factor for ischemic stroke worldwide, but data available from the Indian subcontinent is scarce. Aim : To study homocysteine levels in patients with ischemic stroke and compare it with age- and sex-matched controls. Settings an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology India 2005-09, Vol.53 (3), p.297-301; discussion 301-2
1. Verfasser: Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 301; discussion 301-2
container_issue 3
container_start_page 297
container_title Neurology India
container_volume 53
creator Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP
description Background : Hyperhomocysteinemia has been proposed as an important risk factor for ischemic stroke worldwide, but data available from the Indian subcontinent is scarce. Aim : To study homocysteine levels in patients with ischemic stroke and compare it with age- and sex-matched controls. Settings and Design: Case-control prospective study. Materials and Methods: Fifty-seven patients with ischemic stroke and 30 controls were recruited for the study. They were subdivided into two subgroups (40 years of age) and plasma fasting total homocysteine (tHcy) levels were measured. Statistical analysis used: Student′s ′t′ test and chi-square test. Results: The tHcy were significantly high in patients with stroke, compared to controls (9.91 ± 2.25 vs 8.00 ± 2.74 mmol/l; P < 0.001). Significantly high levels were seen in both male patients compared to controls (10.24 ± 2.34 vs 8.45 ± 2.72 μmol/l; P = 0.01) and female patients compared to controls (9.08 ± 1.81 vs 6.79 ± 2.60 μmol/l; P = 0.04). The tHcy levels were significantly high in patients with hypertension compared to normotensive patients (10.96 vs 9.49 μmol/l; P = 0.01) and smokers compared to nonsmokers (11.17 vs 9.33 μol/l; P = 0.01). Conclusions : Hyperhomo-cysteinemia emerged as an important independent risk factor for ischemic stroke. A strong positive correlation was also observed between hypertension, smoking, and high-tHcy levels in the present study.
doi_str_mv 10.4103/0028-3886.16927
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68705630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A137849465</galeid><sourcerecordid>A137849465</sourcerecordid><originalsourceid>FETCH-LOGICAL-b479t-1e501abaa46d6079820c95d33d19153ca080b2d8966c3f71b48bb1a196a1b4443</originalsourceid><addsrcrecordid>eNptkU1vGyEQhlHUKHaTnHurUA-5rc3XstCbFTVNJFe5tGc0y7IJ8S64sD743xfXbiJVEaCBmWfgFS9CnyhZCEr4khCmKq6UXFCpWXOG5lRrVQnC2Ac0f63O0MecX8qRc8ou0IxKxkmj5Rz9uN9vXXqOY7T7PDkf3OgBQ8aAk88b3IOdYsJ9WT7b51K1OE8pbtxXvAr4IXQeAs7WBUg-XqHzHobsrk_xEv26-_bz9r5aP35_uF2tq1Y0eqqoqwmFFkDIThYdihGr647zjmpacwtEkZZ1Sktped_QVqi2pUC1hLIXgl-im-O92xR_71yezFjUuWGA4OIuG6kaUktOCvjlP_Al7lIo2gzjUsumkbxA1RF6gsEZH_o4JbBPLrgEQwyu9yW9orxRQgtZF37xDl9Gd_iedxuWxwabYs7J9Wab_AhpbygxBx_NwSlzcMr89bF0fD7p3rWj6974k3FvGlofh-LaK2GTB_MvGXyZpC4v8D8kM6Zk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>236967763</pqid></control><display><type>article</type><title>Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Bioline International</source><creator>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</creator><creatorcontrib>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</creatorcontrib><description>Background : Hyperhomocysteinemia has been proposed as an important risk factor for ischemic stroke worldwide, but data available from the Indian subcontinent is scarce. Aim : To study homocysteine levels in patients with ischemic stroke and compare it with age- and sex-matched controls. Settings and Design: Case-control prospective study. Materials and Methods: Fifty-seven patients with ischemic stroke and 30 controls were recruited for the study. They were subdivided into two subgroups (&lt;40 years and &gt;40 years of age) and plasma fasting total homocysteine (tHcy) levels were measured. Statistical analysis used: Student′s ′t′ test and chi-square test. Results: The tHcy were significantly high in patients with stroke, compared to controls (9.91 ± 2.25 vs 8.00 ± 2.74 mmol/l; P &lt; 0.001). Significantly high levels were seen in both male patients compared to controls (10.24 ± 2.34 vs 8.45 ± 2.72 μmol/l; P = 0.01) and female patients compared to controls (9.08 ± 1.81 vs 6.79 ± 2.60 μmol/l; P = 0.04). The tHcy levels were significantly high in patients with hypertension compared to normotensive patients (10.96 vs 9.49 μmol/l; P = 0.01) and smokers compared to nonsmokers (11.17 vs 9.33 μol/l; P = 0.01). Conclusions : Hyperhomo-cysteinemia emerged as an important independent risk factor for ischemic stroke. A strong positive correlation was also observed between hypertension, smoking, and high-tHcy levels in the present study.</description><identifier>ISSN: 0028-3886</identifier><identifier>EISSN: 1998-4022</identifier><identifier>DOI: 10.4103/0028-3886.16927</identifier><identifier>PMID: 16230796</identifier><language>eng</language><publisher>India: Medknow Publications on behalf of the Neurological Society of India</publisher><subject>Adult ; Brain Ischemia - epidemiology ; Case-Control Studies ; Case-control study ; Female ; Health aspects ; Homocysteine ; Humans ; Hyperhomocysteinemia - complications ; India - epidemiology ; Ischemia ; ischemic stroke ; Male ; Middle Aged ; Risk Factors ; Stroke - epidemiology</subject><ispartof>Neurology India, 2005-09, Vol.53 (3), p.297-301; discussion 301-2</ispartof><rights>Copyright 2005 Neurology India.</rights><rights>COPYRIGHT 2005 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications Jul-Sep 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b479t-1e501abaa46d6079820c95d33d19153ca080b2d8966c3f71b48bb1a196a1b4443</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16230796$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</creatorcontrib><title>Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario</title><title>Neurology India</title><addtitle>Neurol India</addtitle><description>Background : Hyperhomocysteinemia has been proposed as an important risk factor for ischemic stroke worldwide, but data available from the Indian subcontinent is scarce. Aim : To study homocysteine levels in patients with ischemic stroke and compare it with age- and sex-matched controls. Settings and Design: Case-control prospective study. Materials and Methods: Fifty-seven patients with ischemic stroke and 30 controls were recruited for the study. They were subdivided into two subgroups (&lt;40 years and &gt;40 years of age) and plasma fasting total homocysteine (tHcy) levels were measured. Statistical analysis used: Student′s ′t′ test and chi-square test. Results: The tHcy were significantly high in patients with stroke, compared to controls (9.91 ± 2.25 vs 8.00 ± 2.74 mmol/l; P &lt; 0.001). Significantly high levels were seen in both male patients compared to controls (10.24 ± 2.34 vs 8.45 ± 2.72 μmol/l; P = 0.01) and female patients compared to controls (9.08 ± 1.81 vs 6.79 ± 2.60 μmol/l; P = 0.04). The tHcy levels were significantly high in patients with hypertension compared to normotensive patients (10.96 vs 9.49 μmol/l; P = 0.01) and smokers compared to nonsmokers (11.17 vs 9.33 μol/l; P = 0.01). Conclusions : Hyperhomo-cysteinemia emerged as an important independent risk factor for ischemic stroke. A strong positive correlation was also observed between hypertension, smoking, and high-tHcy levels in the present study.</description><subject>Adult</subject><subject>Brain Ischemia - epidemiology</subject><subject>Case-Control Studies</subject><subject>Case-control study</subject><subject>Female</subject><subject>Health aspects</subject><subject>Homocysteine</subject><subject>Humans</subject><subject>Hyperhomocysteinemia - complications</subject><subject>India - epidemiology</subject><subject>Ischemia</subject><subject>ischemic stroke</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Risk Factors</subject><subject>Stroke - epidemiology</subject><issn>0028-3886</issn><issn>1998-4022</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>RBI</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkU1vGyEQhlHUKHaTnHurUA-5rc3XstCbFTVNJFe5tGc0y7IJ8S64sD743xfXbiJVEaCBmWfgFS9CnyhZCEr4khCmKq6UXFCpWXOG5lRrVQnC2Ac0f63O0MecX8qRc8ou0IxKxkmj5Rz9uN9vXXqOY7T7PDkf3OgBQ8aAk88b3IOdYsJ9WT7b51K1OE8pbtxXvAr4IXQeAs7WBUg-XqHzHobsrk_xEv26-_bz9r5aP35_uF2tq1Y0eqqoqwmFFkDIThYdihGr647zjmpacwtEkZZ1Sktped_QVqi2pUC1hLIXgl-im-O92xR_71yezFjUuWGA4OIuG6kaUktOCvjlP_Al7lIo2gzjUsumkbxA1RF6gsEZH_o4JbBPLrgEQwyu9yW9orxRQgtZF37xDl9Gd_iedxuWxwabYs7J9Wab_AhpbygxBx_NwSlzcMr89bF0fD7p3rWj6974k3FvGlofh-LaK2GTB_MvGXyZpC4v8D8kM6Zk</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</creator><general>Medknow Publications on behalf of the Neurological Society of India</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><scope>RBI</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario</title><author>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b479t-1e501abaa46d6079820c95d33d19153ca080b2d8966c3f71b48bb1a196a1b4443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Brain Ischemia - epidemiology</topic><topic>Case-Control Studies</topic><topic>Case-control study</topic><topic>Female</topic><topic>Health aspects</topic><topic>Homocysteine</topic><topic>Humans</topic><topic>Hyperhomocysteinemia - complications</topic><topic>India - epidemiology</topic><topic>Ischemia</topic><topic>ischemic stroke</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Risk Factors</topic><topic>Stroke - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</creatorcontrib><collection>Bioline International</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neurology India</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Modi M, Prabhakar S, Majumdar S, Khullar M, Lal V, Das CP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario</atitle><jtitle>Neurology India</jtitle><addtitle>Neurol India</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>53</volume><issue>3</issue><spage>297</spage><epage>301; discussion 301-2</epage><pages>297-301; discussion 301-2</pages><issn>0028-3886</issn><eissn>1998-4022</eissn><abstract>Background : Hyperhomocysteinemia has been proposed as an important risk factor for ischemic stroke worldwide, but data available from the Indian subcontinent is scarce. Aim : To study homocysteine levels in patients with ischemic stroke and compare it with age- and sex-matched controls. Settings and Design: Case-control prospective study. Materials and Methods: Fifty-seven patients with ischemic stroke and 30 controls were recruited for the study. They were subdivided into two subgroups (&lt;40 years and &gt;40 years of age) and plasma fasting total homocysteine (tHcy) levels were measured. Statistical analysis used: Student′s ′t′ test and chi-square test. Results: The tHcy were significantly high in patients with stroke, compared to controls (9.91 ± 2.25 vs 8.00 ± 2.74 mmol/l; P &lt; 0.001). Significantly high levels were seen in both male patients compared to controls (10.24 ± 2.34 vs 8.45 ± 2.72 μmol/l; P = 0.01) and female patients compared to controls (9.08 ± 1.81 vs 6.79 ± 2.60 μmol/l; P = 0.04). The tHcy levels were significantly high in patients with hypertension compared to normotensive patients (10.96 vs 9.49 μmol/l; P = 0.01) and smokers compared to nonsmokers (11.17 vs 9.33 μol/l; P = 0.01). Conclusions : Hyperhomo-cysteinemia emerged as an important independent risk factor for ischemic stroke. A strong positive correlation was also observed between hypertension, smoking, and high-tHcy levels in the present study.</abstract><cop>India</cop><pub>Medknow Publications on behalf of the Neurological Society of India</pub><pmid>16230796</pmid><doi>10.4103/0028-3886.16927</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-3886
ispartof Neurology India, 2005-09, Vol.53 (3), p.297-301; discussion 301-2
issn 0028-3886
1998-4022
language eng
recordid cdi_proquest_miscellaneous_68705630
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Bioline International
subjects Adult
Brain Ischemia - epidemiology
Case-Control Studies
Case-control study
Female
Health aspects
Homocysteine
Humans
Hyperhomocysteinemia - complications
India - epidemiology
Ischemia
ischemic stroke
Male
Middle Aged
Risk Factors
Stroke - epidemiology
title Hyperhomocysteinemia as a risk factor for ischemic stroke: An Indian scenario
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A11%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperhomocysteinemia%20as%20a%20risk%20factor%20for%20ischemic%20stroke:%20An%20Indian%20scenario&rft.jtitle=Neurology%20India&rft.au=Modi%20M,%20Prabhakar%20S,%20Majumdar%20S,%20Khullar%20M,%20Lal%20V,%20Das%20CP&rft.date=2005-09-01&rft.volume=53&rft.issue=3&rft.spage=297&rft.epage=301;%20discussion%20301-2&rft.pages=297-301;%20discussion%20301-2&rft.issn=0028-3886&rft.eissn=1998-4022&rft_id=info:doi/10.4103/0028-3886.16927&rft_dat=%3Cgale_proqu%3EA137849465%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=236967763&rft_id=info:pmid/16230796&rft_galeid=A137849465&rfr_iscdi=true